Continuous processing of recombinant proteins: Integration of inclusion body solubilization and refolding using simulated moving bed size exclusion chromatography with buffer recycling
Introduction
Protein expression as inclusion bodies provides high yield [1] and purity as high as 90% [2] and this outweighs the disadvantage of the time consuming refolding process. Further improvements may arise from process integration of inclusion body solubilization and refolding on a matrix. A continuous process is the basis for the reduction of footprint, a further increase of productivity, and the possibility of buffer recycling. In protein refolding, the process of correct protein refolding usually is in competition with protein aggregation, where aggregation typically follows a higher order of reaction, at least an order of two or higher [2], [3], [4]. Thus, refolding is commonly performed at concentrations below 0.5 g/L. Proteins in inclusion bodies can be dissolved to extremely high concentrations by chaotropic agents and then diluted into refolding buffer for refolding [5]. Refolding of proteins at dilute concentration is typically performed as a batch operation. Low protein concentrations during refolding are required to achieve reasonable yields, which depend on the folding kinetics and the thermodynamic folding equilibrium and the yields may range from as low as 10% up to 90%, depending on the individual protein [6]. Common to all refolding processes based on batch dilution are high buffer consumption and large reactor volumes, and consequently, low productivities. An alternative to batch dilution refolding is an on-column process also termed matrix-assisted refolding (MAR) where the protein is refolded in the presence of a stationary phase which influences the refolding reaction. Different chromatographic methods have been used for MAR including ion exchange [7], [8], [9], hydrophobic interaction [10], [11], [12], affinity [13], [14], [15], and size exclusion chromatography [2], [16], [17]. Size exclusion chromatography (SEC) is a simple technique for matrix-assisted refolding of proteins. The protein is loaded at high concentrations on the column and eluted using a decreasing chaotrope gradient [16], [18], [19], [20], [21] or refolding buffer. It has been hypothesized that aggregate formation is reduced by the spatial separation within the pores of the SEC beads of aggregated, partly folded, and folded proteins due to the differences in size and the effective diffusivity of unfolded proteins, folded proteins, and aggregates [18]. Hence, the refolding equilibrium is shifted toward the refolded proteins and higher refolding yields are obtained.
The combination of matrix-assisted refolding with continuous processing might increase refolding yield and will intensify the process toward higher productivity and throughput, and lower buffer consumption.
Several continuous refolding processes using SEC have been described. Pressurized continuous annular chromatography (P-CAC) was used for the continuous refolding of α-lactalbumin and lysozyme [22], [23] and simulated moving bed (SMB) for the continuous refolding of lysozyme [24], [25]. Unfolded proteins were continuously separated from chaotropic compounds and transferred to refolding buffer during migration. Continuous refolding with SMB using chaotropes for IB dissolution results in a zone with high chaotrope concentration which affords continuous unfolding of the proteins.
Herein, we present a new concept for a matrix-assisted refolding SMB size exclusion chromatography (MSS) process where the IBs are dissolved with NaOH instead of chaotropes and the folding intermediates and folded proteins are continuously separated from aggregated proteins. This new process has the advantages that the SMB system can be operated isocratically which enables a closed-loop configuration with refolding buffer used as the desorbent buffer and the use of tangential flow filtration (TFF) for recycling of the refolding buffer of the raffinate.
For process evaluation, we used two Npro fusion peptides, EDDIE-pep6His and EDDIE-MCP-1. Npro autoprotease fusion proteins and their mutations are self-cleaving fusion proteins which are used for the production of recombinant peptides and proteins in Escherichia coli [2], [26], [27], [28] and are expressed in large amounts in inclusion bodies. During refolding, the autoprotease Npro becomes active and cleaves itself off from the target protein or peptide leaving it with an authentic N-terminus [29], [30].
IB dissolution with NaOH had to be performed continuously to prevent protein degradation. Therefore, we designed a continuous dissolution reactor with subsequent filtration that involved a tubular reactor design.
Based on the actual refolding data for the two model proteins, we compared the throughput, productivity, and buffer consumption of our MSS process to two batch dilution refolding processes, one using urea for IB dissolution, the other using NaOH for IB dissolution.
Section snippets
Equipment and chemicals
An Octave 10 System (Semba Biosciences, Madison, WI, USA) was used for SMB experiments controlled by SembaPro software version 3.7.2 pre-release 2. An ÄKTA Avant 25 (GE Healthcare, Uppsala, Sweden) controlled by UNICORN software version 6.1 was modified for use with continuous IB filtration and process monitoring. All chemicals were purchased from Sigma (Steinheim, Germany) and Merck (Darmstadt, Germany), if not otherwise stated.
Npro fusion technology
Two Npro fusion peptides were used as model proteins. One was
Continuous dissolution reactor for IBs
The design of the overall process and in particular of the continuous dissolution reactor is based on rapid and efficient dissolution of inclusion bodies by NaOH. Dissolution conditions were determined in small scale batch experiments. IBs were completely dissolved by a 1:5 dilution in NaOH and subsequent reduction with MTG in approximately 1 min at final NaOH and MTG concentrations of 75 and 15 mM, respectively. These reaction conditions were the basis for the design of the continuous
Discussion
The experiments included herein proved the concept that a combination of continuous IB dissolution with NaOH and continuous refolding by SMB was a successful process for the production of prepurified protein product. The primary objective was to recycle buffer by a closed-loop SMB configuration and by concentrating the raffinate with TFF to substantially reduce the buffer consumption. Buffer consumption is a major cost driver in downstream processing of protein expressed as inclusion bodies.
Conclusions
On a small scale, we have demonstrated that it is possible to combine continuous inclusion body dissolution, continuous refolding, and buffer recycling by closed-loop SMB. This procedure was demonstrated with real IB suspensions produced in E. coli. Such a design allows the recycling of refolding buffer in the range of >98%. In addition, the refolding reaction is enhanced which further increased productivity of this method. This integrated process is a further contribution to the continuous
Acknowledgements
We thank the group of G. Striedner for fermentation of the Npro proteins and A. Trefilov for isolation of IBs. This work has been supported by the Federal Ministry of Economy, Family and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation and Technology (bmvit), the Styrian Business Promotion Agency SFG, the Standortagentur Tirol and ZIT – Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG.
References (38)
- et al.
J. Biotechnol.
(2007) Trends Biotechnol.
(2002)- et al.
Curr. Opin. Biotechnol.
(1998) - et al.
J. Chromatogr. A
(2009) - et al.
J. Chromatogr. A
(2010) - et al.
J. Chromatogr. A
(2004) - et al.
Protein Expr. Purif.
(2003) - et al.
J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.
(2003) - et al.
Protein Expr. Purif.
(2003) - et al.
J. Chromatogr. A
(2007)
J. Chromatogr. A
J. Chromatogr. A
J. Chromatogr. A
J. Chromatogr. A
J. Chromatogr. A
Chem. Eng. Sci.
Process Biochem.
Process Biochem.
J. Chromatogr. A
Cited by (23)
A risk-aware assessment for buffer recycling across unit operations for monoclonal antibody purification and its potential
2024, Biochemical Engineering JournalChromatography assisted in-vitro refolding and purification of recombinant peptibody: Recombinant Romiplostim a case study
2023, International Journal of Biological MacromoleculesContinuous protein refolding and purification by two-stage periodic counter-current chromatography
2023, Journal of Chromatography ARefolding in the modern biopharmaceutical industry
2022, Biotechnology AdvancesContinuous refolding of L-asparaginase inclusion bodies using periodic counter-current chromatography
2022, Journal of Chromatography AMicrobial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and control
2020, Drug Discovery Today: TechnologiesCitation Excerpt :Low target product concentrations in the refolding step result in large processing volumes at manufacturing scale, necessitating the use of large tanks and requiring proper buffer handling. Therefore, either model-based approaches in refolding [74] or continuous refolding could become a future perspective, reducing the scale and buffer consumption of the process step [75]. Usually, soluble proteins are expressed into the periplasm (E. coli) or extracellularly (P. pastoris), hence no cell disruption is necessary [35].